Search Keyword:


Search option:


IID00961
UniprotP78536
ProteinDisintegrin and metalloproteinase domain-containing protein 17
GeneADAM17
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
824
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 212-492 Monomer :
 Evidence X-RAY 1bkc A Reference
       Region 1bkc A 219-473 order
       Region 1bkc A 474-474 disorder
 Evidence X-RAY 1bkc E Reference
       Region 1bkc E 219-474 order
 Evidence X-RAY 1bkc C Reference
       Region 1bkc C 219-220 disorder
       Region 1bkc C 221-474 order
 Evidence X-RAY 1bkc I Reference
       Region 1bkc I 219-220 disorder
       Region 1bkc I 221-474 order
 Evidence X-RAY 1zxc A Reference
       Region 1zxc A 215-216 disorder
       Region 1zxc A 217-475 order
       Region 1zxc A 476-477 disorder
 Evidence X-RAY 1zxc B Reference
       Region 1zxc B 215-217 disorder
       Region 1zxc B 218-475 order
       Region 1zxc B 476-477 disorder
 Evidence X-RAY 2a8h A Reference
       Region 2a8h A 215-216 disorder
       Region 2a8h A 217-475 order
       Region 2a8h A 476-477 disorder
 Evidence X-RAY 2a8h B Reference
       Region 2a8h B 215-217 disorder
       Region 2a8h B 218-474 order
       Region 2a8h B 475-477 disorder
 Evidence X-RAY 2ddf A Reference
       Region 2ddf A 218-356 order
       Region 2ddf A 357-360 disorder
       Region 2ddf A 361-474 order
 Evidence X-RAY 2ddf B Reference
       Region 2ddf B 218-219 disorder
       Region 2ddf B 220-473 order
       Region 2ddf B 474-474 disorder
 Evidence X-RAY 2fv5 A Reference
       Region 2fv5 A 216-475 order
 Evidence X-RAY 2fv5 B Reference
       Region 2fv5 B 216-219 disorder
       Region 2fv5 B 220-475 order
 Evidence X-RAY 2fv9 A Reference
       Region 2fv9 A 218-356 order
       Region 2fv9 A 357-360 disorder
       Region 2fv9 A 361-475 order
 Evidence X-RAY 2fv9 B Reference
       Region 2fv9 B 218-219 disorder
       Region 2fv9 B 220-473 order
       Region 2fv9 B 474-475 disorder
 Evidence X-RAY 2i47 A Reference
       Region 2i47 A 212-219 disorder
       Region 2i47 A 220-474 order
       Region 2i47 A 475-492 disorder
 Evidence X-RAY 2i47 B Reference
       Region 2i47 B 212-220 disorder
       Region 2i47 B 221-474 order
       Region 2i47 B 475-492 disorder
 Evidence X-RAY 2i47 C Reference
       Region 2i47 C 212-220 disorder
       Region 2i47 C 221-474 order
       Region 2i47 C 475-492 disorder
 Evidence X-RAY 2i47 D Reference
       Region 2i47 D 212-219 disorder
       Region 2i47 D 220-474 order
       Region 2i47 D 475-492 disorder
 Evidence X-RAY 2oi0 A Reference
       Region 2oi0 A 216-477 order
 Evidence X-RAY 3b92 A Reference
       Region 3b92 A 216-474 order
 Evidence X-RAY 3e8r A Reference
       Region 3e8r A 215-217 disorder
       Region 3e8r A 218-356 order
       Region 3e8r A 357-360 disorder
       Region 3e8r A 361-439 order
       Region 3e8r A 440-441 disorder
       Region 3e8r A 442-474 order
       Region 3e8r A 475-477 disorder
 Evidence X-RAY 3e8r B Reference
       Region 3e8r B 215-219 disorder
       Region 3e8r B 220-473 order
       Region 3e8r B 474-477 disorder
 Evidence X-RAY 3edz A Reference
       Region 3edz A 215-217 disorder
       Region 3edz A 218-475 order
       Region 3edz A 476-477 disorder
 Evidence X-RAY 3edz B Reference
       Region 3edz B 215-219 disorder
       Region 3edz B 220-473 order
       Region 3edz B 474-477 disorder
 Evidence X-RAY 3ewj A Reference
       Region 3ewj A 215-217 disorder
       Region 3ewj A 218-356 order
       Region 3ewj A 357-360 disorder
       Region 3ewj A 361-475 order
       Region 3ewj A 476-477 disorder
 Evidence X-RAY 3ewj B Reference
       Region 3ewj B 215-219 disorder
       Region 3ewj B 220-474 order
       Region 3ewj B 475-477 disorder
 Evidence X-RAY 3g42 A Reference
       Region 3g42 A 212-220 disorder
       Region 3g42 A 221-474 order
       Region 3g42 A 475-492 disorder
 Evidence X-RAY 3g42 B Reference
       Region 3g42 B 212-220 disorder
       Region 3g42 B 221-474 order
       Region 3g42 B 475-492 disorder
 Evidence X-RAY 3g42 C Reference
       Region 3g42 C 212-218 disorder
       Region 3g42 C 219-474 order
       Region 3g42 C 475-492 disorder
 Evidence X-RAY 3g42 D Reference
       Region 3g42 D 212-219 disorder
       Region 3g42 D 220-473 order
       Region 3g42 D 474-492 disorder
 Evidence X-RAY 3kmc A Reference
       Region 3kmc A 215-217 disorder
       Region 3kmc A 218-356 order
       Region 3kmc A 357-358 disorder
       Region 3kmc A 359-474 order
       Region 3kmc A 475-476 disorder
 Evidence X-RAY 3kmc B Reference
       Region 3kmc B 215-219 disorder
       Region 3kmc B 220-473 order
       Region 3kmc B 474-476 disorder
 Evidence X-RAY 3kme A Reference
       Region 3kme A 215-217 disorder
       Region 3kme A 218-356 order
       Region 3kme A 357-360 disorder
       Region 3kme A 361-474 order
       Region 3kme A 475-476 disorder
 Evidence X-RAY 3kme B Reference
       Region 3kme B 215-219 disorder
       Region 3kme B 220-473 order
       Region 3kme B 474-476 disorder
 Evidence X-RAY 3l0t A Reference
       Region 3l0t A 215-217 disorder
       Region 3l0t A 218-356 order
       Region 3l0t A 357-359 disorder
       Region 3l0t A 360-474 order
       Region 3l0t A 475-476 disorder
 Evidence X-RAY 3l0t B Reference
       Region 3l0t B 215-219 disorder
       Region 3l0t B 220-473 order
       Region 3l0t B 474-476 disorder
 Evidence X-RAY 3l0v A Reference
       Region 3l0v A 215-215 disorder
       Region 3l0v A 216-356 order
       Region 3l0v A 357-360 disorder
       Region 3l0v A 361-474 order
       Region 3l0v A 475-476 disorder
 Evidence X-RAY 3l0v B Reference
       Region 3l0v B 215-219 disorder
       Region 3l0v B 220-354 order
       Region 3l0v B 355-356 disorder
       Region 3l0v B 357-473 order
       Region 3l0v B 474-476 disorder
 Evidence X-RAY 3le9 A Reference
       Region 3le9 A 215-217 disorder
       Region 3le9 A 218-354 order
       Region 3le9 A 355-360 disorder
       Region 3le9 A 361-474 order
       Region 3le9 A 475-476 disorder
 Evidence X-RAY 3le9 B Reference
       Region 3le9 B 215-219 disorder
       Region 3le9 B 220-354 order
       Region 3le9 B 355-356 disorder
       Region 3le9 B 357-473 order
       Region 3le9 B 474-476 disorder
 Evidence X-RAY 3lea A Reference
       Region 3lea A 215-216 disorder
       Region 3lea A 217-474 order
       Region 3lea A 475-476 disorder
 Evidence X-RAY 3lea B Reference
       Region 3lea B 215-475 order
       Region 3lea B 476-476 disorder
 Evidence X-RAY 3lgp A Reference
       Region 3lgp A 215-217 disorder
       Region 3lgp A 218-354 order
       Region 3lgp A 355-360 disorder
       Region 3lgp A 361-474 order
       Region 3lgp A 475-476 disorder
 Evidence X-RAY 3lgp B Reference
       Region 3lgp B 215-219 disorder
       Region 3lgp B 220-473 order
       Region 3lgp B 474-476 disorder
 Evidence X-RAY 3o64 A Reference
       Region 3o64 A 215-216 disorder
       Region 3o64 A 217-354 order
       Region 3o64 A 355-360 disorder
       Region 3o64 A 361-474 order
       Region 3o64 A 475-476 disorder
 Evidence X-RAY 3o64 B Reference
       Region 3o64 B 215-220 disorder
       Region 3o64 B 221-473 order
       Region 3o64 B 474-476 disorder
Seq 219-474 Hetero dimer : P35625
 Evidence X-RAY 3cki A Reference
       Region 3cki A 219-474 order
Seq 581-642 Monomer :
 Evidence NMR 2m2f A Reference
       Region 2m2f A 581-642 order
Seq 813-824 Hetero dimer : P26045
 Evidence X-RAY 8cqy B Reference
       Region 8cqy B 813-818 disorder
       Region 8cqy B 819-824 order
SeqProS predicted 819-824 This region is predicted to be disordered by AlphaFold (pLDDT <68.5) and NeProc; PDZ-binding motif (PBM) Hetero dimer : P26045
       Region 8cqy B 819-824 order
Seqphosphorylation
    819-819 Phosphoserine
    791-791 Phosphoserine
    767-767 Phosphoserine
    761-761 Phosphothreonine
    735-735 Phosphothreonine; by MAPK14
 
Prediction
NeProc
Disorder 1-34,57-61,170-212,360-371,695-824
Order 35-52,62-169,213-359,372-694
ProS 1-24,57-61,170-212,360-371,695-709,714-717,763-781,791-799,807-824
AlphaFold
Disorder 1-33,54-65,86-92,174-218,269-271,438-441,443-443,475-477,493-497,643-665,702-824
Order 34-53,66-85,93-173,219-268,272-437,442-442,444-474,478-492,498-642,666-701
SEG 35-48 ,741-752
Function
Function in SwissProt
Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form (PubMed:9034191). Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface (PubMed:20592283). Responsible for the proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein (PubMed:12441351). Acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT) (PubMed:24226769). Plays a role in the proteolytic processing of ACE2 (PubMed:24227843). Plays a role in hemostasis through shedding of GP1BA, the platelet glycoprotein Ib alpha chain (By similarity). Mediates the proteolytic cleavage of LAG3, leading to release the secreted form of LAG3 (By similarity). Mediates the proteolytic cleavage of IL6R, leading to the release of secreted form of IL6R (PubMed:26876177, PubMed:28060820). Mediates the proteolytic cleavage and shedding of FCGR3A upon NK cell stimulation, a mechanism that allows for increased NK cell motility and detachment from opsonized target cells.